Niagen Bioscience Inc (NAGE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Sales | 31,474 | 33,839 | 33,986 | 31,117 | 30,481 |
| Cost of Goods | 11,498 | 12,135 | 12,058 | 10,891 | 11,150 |
| Gross Profit | 19,976 | 21,704 | 21,928 | 20,226 | 19,331 |
| Operating Expenses | 18,898 | 17,753 | 17,750 | 17,932 | 14,709 |
| Operating Income | 1,576 | 4,086 | 4,236 | 3,185 | 4,772 |
| Other Income | 5,159 | 338 | 564 | 552 | 459 |
| Pre-tax Income | 6,735 | 4,424 | 4,800 | 3,737 | 5,231 |
| Income Tax | 417 | 292 | 222 | 128 | 168 |
| Net Income Continuous | 6,318 | 4,132 | 4,578 | 3,609 | 5,063 |
| Net Income | $6,318 | $4,132 | $4,578 | $3,609 | $5,063 |
| EPS Basic Total Ops | 0.08 | 0.04 | 0.06 | 0.05 | 0.07 |
| EPS Basic Continuous Ops | 0.08 | 0.05 | 0.06 | 0.05 | 0.07 |
| EPS Diluted Total Ops | 0.07 | 0.05 | 0.05 | 0.04 | 0.06 |
| EPS Diluted Continuous Ops | 0.07 | 0.05 | 0.05 | 0.04 | 0.06 |
| EPS Diluted Before Non-Recurring Items | 0.07 | 0.03 | 0.05 | 0.04 | 0.04 |
| EBITDA(a) | $1,867 | $4,285 | $4,431 | $3,381 | $4,967 |